Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedMinor revision updates were applied: v3.4.2 added and v3.4.1 removed, with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0 in the metadata. This is a minor versioning update and does not alter study content or functionality.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows a glossary and QC-related metadata (Last Update Submitted that Met QC Criteria) along with No FEAR Act Data and Revision: v3.4.0. The older QC field capitalization (Last Update Submitted that met QC Criteria), the No FEAR Act data, and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.3.4 replaced the prior v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.